Literature DB >> 18988702

Technical approach to iliac crest biopsy.

Joel D Hernandez1, Katherine Wesseling, Renata Pereira, Barbara Gales, Rick Harrison, Isidro B Salusky.   

Abstract

Bone histomorphometry has been the gold standard in the evaluation and diagnosis of renal osteodystrophy. The recent new definition of renal osteodystrophy as chronic kidney disease-mineral and bone disorder has once again highlighted the use of bone biopsy as a powerful and diagnostic tool to determine skeletal abnormalities in chronic kidney disease. The procedure of iliac crest bone biopsy has been proved safe and associated with very minimal morbidity. In this review, the clinical indications, preparation, instrumentation, and potential complications are discussed. Because current biochemical markers are poor predictors of bone turnover, volume, and mineralization, a wider use of bone biopsy and histomorphometry will lead to a better understanding of the bone and mineral disorders that are associated with chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18988702      PMCID: PMC3152282          DOI: 10.2215/CJN.00460107

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  18 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  S Moe; T Drüeke; J Cunningham; W Goodman; K Martin; K Olgaard; S Ott; S Sprague; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

3.  Percutaneous biopsy of the iliac crest.

Authors:  K A Johnson; P J Kelly; J Jowsey
Journal:  Clin Orthop Relat Res       Date:  1977 Mar-Apr       Impact factor: 4.176

4.  A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.

Authors:  M R John; W G Goodman; P Gao; T L Cantor; I B Salusky; H Jüppner
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

5.  Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.

Authors:  I B Salusky; J A Ramirez; W Oppenheim; B Gales; G V Segre; W G Goodman
Journal:  Kidney Int       Date:  1994-01       Impact factor: 10.612

Review 6.  Iliac crest bone biopsy for diagnosis of aluminum toxicity and a guide to the use of deferoxamine.

Authors:  K C Norris; W G Goodman; N Howard; M E Nugent; J W Coburn
Journal:  Semin Nephrol       Date:  1986-12       Impact factor: 5.299

7.  The spectrum of bone disease in end-stage renal failure--an evolving disorder.

Authors:  D J Sherrard; G Hercz; Y Pei; N A Maloney; C Greenwood; A Manuel; C Saiphoo; S S Fenton; G V Segre
Journal:  Kidney Int       Date:  1993-02       Impact factor: 10.612

8.  Bone biopsy: indications, techniques, and complications.

Authors:  David Trueba; B Peter Sawaya; Hanna Mawad; Hartmut H Malluche
Journal:  Semin Dial       Date:  2003 Jul-Aug       Impact factor: 3.455

9.  Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.

Authors:  I B Salusky; J W Coburn; J Brill; J Foley; E Slatopolsky; R N Fine; W G Goodman
Journal:  Kidney Int       Date:  1988-05       Impact factor: 10.612

10.  Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.

Authors:  W G Goodman; J A Ramirez; T R Belin; Y Chon; B Gales; G V Segre; I B Salusky
Journal:  Kidney Int       Date:  1994-10       Impact factor: 10.612

View more
  21 in total

1.  Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone quality.

Authors:  Astrid Starke; Alf Corsenca; Thomas Kohler; Johannes Knubben; Marius Kraenzlin; Daniel Uebelhart; Rudolf P Wüthrich; Brigitte von Rechenberg; Ralph Müller; Patrice M Ambühl
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-05       Impact factor: 8.237

2.  Cortical bone analysis in a predialysis population: a comparison with a dialysis population.

Authors:  Catarina Carvalho; J Magalhães; R Neto; L Pereira; P Branco; T Adragão; J M Frazão
Journal:  J Bone Miner Metab       Date:  2016-11-09       Impact factor: 2.626

Review 3.  Bone impairment in primary hyperoxaluria: a review.

Authors:  Justine Bacchetta; Georges Boivin; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2015-01-29       Impact factor: 3.714

4.  Vertebral bone density by quantitative computed tomography mirrors bone structure histomorphometric parameters in hemodialysis patients.

Authors:  Aluizio Barbosa Carvalho; Ricardo Carneiro; Graziella M Leme; Carlos E Rochitte; Raul D Santos; Márcio H Miname; Rosa M Moyses; Vanda Jorgetti; Maria Eugênia F Canziani
Journal:  J Bone Miner Metab       Date:  2013-03-21       Impact factor: 2.626

5.  The unexpected presence of iron in bone biopsies of hemodialysis patients.

Authors:  Melani R Custodio; Rosilene M Elias; Wagner D Velasquez; Luciene M Dos Reis; Ivone B Oliveira; Rosa M A Moysés; Aluizio B Carvalho; Vanda Jorgetti
Journal:  Int Urol Nephrol       Date:  2018-08-22       Impact factor: 2.370

Review 6.  The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives.

Authors:  Catarina Carvalho; Catarina Moniz Alves; João Miguel Frazão
Journal:  J Nephrol       Date:  2016-07-29       Impact factor: 3.902

7.  Racial differences in bone histomorphometry in children and young adults treated with dialysis.

Authors:  Marciana Laster; Renata C Pereira; Isidro B Salusky
Journal:  Bone       Date:  2019-06-07       Impact factor: 4.398

8.  Cortical and trabecular bone in pediatric end-stage kidney disease.

Authors:  Catarina G Carvalho; Renata C Pereira; Barbara Gales; Isidro B Salusky; Katherine Wesseling-Perry
Journal:  Pediatr Nephrol       Date:  2014-09-04       Impact factor: 3.714

Review 9.  Update on the role of bone biopsy in the management of patients with CKD-MBD.

Authors:  P Evenepoel; G J S Behets; M R Laurent; P C D'Haese
Journal:  J Nephrol       Date:  2017-08-22       Impact factor: 3.902

10.  The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial.

Authors:  Justine Bacchetta; Katherine Wesseling-Perry; Beatriz Kuizon; Renata C Pereira; Barbara Gales; He-jing Wang; Robert Elashoff; Isidro B Salusky
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-04       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.